Suppr超能文献

肥胖症在高功能、非瘫痪的脊髓性肌萎缩症患者中更为常见。

Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy.

机构信息

Division of Pediatric Neurosciences, Department of Neurology, SMA Clinical Research Center, Columbia University Medical Center, New York, NY 10032-3791, USA.

出版信息

Neuromuscul Disord. 2010 Jul;20(7):448-52. doi: 10.1016/j.nmd.2010.05.013. Epub 2010 Jun 17.

Abstract

The relationship between body composition and function in spinal muscular atrophy (SMA) is poorly understood. 53 subjects with SMA were stratified by type and Hammersmith functional motor scale, expanded score into three cohorts: low-functioning non-ambulatory (type 2 with Hammersmith score < 12, n=19), high-functioning non-ambulatory (type 2 with Hammersmith score > or = 12 or non-ambulatory type 3, n=17), and Ambulatory (n=17). Lean and fat mass was estimated using dual-energy X-ray absorptiometry. Anthropometric data was incorporated to measure fat-free (lean mass in kg/stature in m(2)) and fat (fat mass in kg/stature in m(2)) mass indices, the latter compared to published age and sex norms. Feeding dysfunction among type 2 subjects was assessed by questionnaire. Fat mass index was increased in the high-functioning non-ambulatory cohort (10.4+/-4.5) compared with both the ambulatory (7.2+/-2.1, P=0.013) and low-functioning non-ambulatory (7.6+/-3.1, P=0.040) cohorts. 12 of 17 subjects (71%) in the high-functioning non-ambulatory cohort had fat mass index > 85th percentile for age and gender (connoting "at risk of overweight") versus 9 of 19 subjects (47%) in the low-functioning non-ambulatory cohort and 8 of 17 ambulatory subjects (47%). Despite differences in clinical function, a similar proportion of low functioning (7/18, 39%) and high functioning (2/7, 29%) type 2 subjects reported swallowing or feeding dysfunction. Non-ambulatory patients with relatively high clinical function may be at particular risk of excess adiposity, perhaps reflecting access to excess calories despite relative immobility, emphasizing the importance of individualized nutritional management in SMA.

摘要

脊髓性肌萎缩症(SMA)患者的身体成分与功能之间的关系尚不清楚。我们将 53 名 SMA 患者按照类型和哈默史密斯运动功能量表评分进行分层,分为三组:低功能非运动(2 型,哈默史密斯评分<12,n=19)、高功能非运动(2 型,哈默史密斯评分≥12 或非运动型 3 型,n=17)和运动(n=17)。使用双能 X 射线吸收法估计瘦体重和脂肪量。采用人体测量数据来测量无脂肪(瘦体重,kg/身高,m2)和脂肪(脂肪量,kg/身高,m2)质量指数,后者与公布的年龄和性别标准进行比较。通过问卷评估 2 型患者的喂养功能障碍。高功能非运动组的脂肪质量指数(10.4±4.5)高于运动组(7.2±2.1,P=0.013)和低功能非运动组(7.6±3.1,P=0.040)。高功能非运动组 17 名患者中有 12 名(71%)的脂肪质量指数大于年龄和性别 85%分位数(意味着“超重风险”),而低功能非运动组 19 名患者中有 9 名(47%)和运动组 17 名患者中有 8 名(47%)。尽管临床功能存在差异,但低功能(7/18,39%)和高功能(2/7,29%)2 型患者报告吞咽或喂养功能障碍的比例相似。具有相对较高临床功能的非运动患者可能面临超重的特殊风险,这可能反映了尽管相对不活动,但仍能获得过多的卡路里,这强调了 SMA 中个体化营养管理的重要性。

相似文献

1
Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy.
Neuromuscul Disord. 2010 Jul;20(7):448-52. doi: 10.1016/j.nmd.2010.05.013. Epub 2010 Jun 17.
2
Bioelectrical impedance analysis can be a useful screen for excess adiposity in spinal muscular atrophy.
J Child Neurol. 2010 Nov;25(11):1348-54. doi: 10.1177/0883073810365185. Epub 2010 Apr 13.
3
Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy.
Neuromuscul Disord. 2009 Jun;19(6):391-6. doi: 10.1016/j.nmd.2009.03.009. Epub 2009 May 7.
4
Comprehensive nutritional and metabolic assessment in patients with spinal muscular atrophy: Opportunity for an individualized approach.
Neuromuscul Disord. 2018 Jun;28(6):512-519. doi: 10.1016/j.nmd.2018.03.009. Epub 2018 Mar 19.
5
Responsiveness of the motor function measure in patients with spinal muscular atrophy.
Arch Phys Med Rehabil. 2013 Aug;94(8):1555-61. doi: 10.1016/j.apmr.2013.01.014. Epub 2013 Feb 1.
6
Evaluation of body composition as a potential biomarker in spinal muscular atrophy.
Muscle Nerve. 2020 Apr;61(4):530-534. doi: 10.1002/mus.26823. Epub 2020 Feb 7.
7
Phase II open label study of valproic acid in spinal muscular atrophy.
PLoS One. 2009;4(5):e5268. doi: 10.1371/journal.pone.0005268. Epub 2009 May 14.
8
Spinal Muscular Atrophy, types I and II: What are the differences in body composition and resting energy expenditure?
Clin Nutr. 2017 Dec;36(6):1674-1680. doi: 10.1016/j.clnu.2016.10.020. Epub 2016 Nov 16.
9
Body composition phenotypes and bone health in young adults: A cluster analysis.
Clin Nutr. 2023 Jul;42(7):1161-1167. doi: 10.1016/j.clnu.2023.05.006. Epub 2023 May 12.

引用本文的文献

3
Body mass index in type 2 spinal muscular atrophy: a longitudinal study.
Eur J Pediatr. 2022 May;181(5):1923-1932. doi: 10.1007/s00431-021-04325-3. Epub 2022 Jan 19.
4
Association Between Body Mass Index and Disability in Children With Charcot-Marie-Tooth Disease.
Neurology. 2021 Oct 26;97(17):e1727-e1736. doi: 10.1212/WNL.0000000000012725. Epub 2021 Sep 7.
5
Growth patterns in children with spinal muscular atrophy.
Orphanet J Rare Dis. 2021 Sep 4;16(1):375. doi: 10.1186/s13023-021-02015-9.
7
Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review.
Orphanet J Rare Dis. 2020 Mar 12;15(1):70. doi: 10.1186/s13023-020-1339-3.
8
Spinal Muscular Atrophy, types I and II: What are the differences in body composition and resting energy expenditure?
Clin Nutr. 2017 Dec;36(6):1674-1680. doi: 10.1016/j.clnu.2016.10.020. Epub 2016 Nov 16.
9
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials.
Neuromuscul Disord. 2016 Feb;26(2):126-31. doi: 10.1016/j.nmd.2015.10.006. Epub 2015 Dec 3.
10
Spinal Muscular Atrophy.
Neurol Clin. 2015 Nov;33(4):831-46. doi: 10.1016/j.ncl.2015.07.004.

本文引用的文献

1
Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy.
Neuromuscul Disord. 2009 Jun;19(6):391-6. doi: 10.1016/j.nmd.2009.03.009. Epub 2009 May 7.
2
Daily salbutamol in young patients with SMA type II.
Neuromuscul Disord. 2008 Jul;18(7):536-40. doi: 10.1016/j.nmd.2008.05.004. Epub 2008 Jun 24.
3
Feeding problems and malnutrition in spinal muscular atrophy type II.
Neuromuscul Disord. 2008 May;18(5):389-93. doi: 10.1016/j.nmd.2008.02.008. Epub 2008 Apr 16.
4
The changing natural history of spinal muscular atrophy type 1.
Neurology. 2007 Nov 13;69(20):1931-6. doi: 10.1212/01.wnl.0000290830.40544.b9.
5
Metabolic syndrome in adolescents with spinal cord dysfunction.
J Spinal Cord Med. 2007;30 Suppl 1(Suppl 1):S127-39. doi: 10.1080/10790268.2007.11754591.
6
Impact of spinal cord dysfunction and obesity on the health-related quality of life of children and adolescents.
J Spinal Cord Med. 2007;30 Suppl 1(Suppl 1):S112-8. doi: 10.1080/10790268.2007.11754614.
7
Body mass index and body composition measures by dual x-ray absorptiometry in patients aged 10 to 21 years with spinal cord injury.
J Spinal Cord Med. 2007;30 Suppl 1(Suppl 1):S97-104. doi: 10.1080/10790268.2007.11754612.
8
Consensus statement for standard of care in spinal muscular atrophy.
J Child Neurol. 2007 Aug;22(8):1027-49. doi: 10.1177/0883073807305788.
9
Spinal muscular atrophy: clinical classification and disease heterogeneity.
J Child Neurol. 2007 Aug;22(8):946-51. doi: 10.1177/0883073807305673.
10
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients.
Neuromuscul Disord. 2007 Oct;17(9-10):693-7. doi: 10.1016/j.nmd.2007.05.009. Epub 2007 Jul 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验